Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Modulation of Caspase-Independent Cell Death Leads to Resensitization of Imatinib Mesylate–Resistant Cells
2009
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
2009 StandoutScience
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
2016
Adjuvant Whole Brain Radiotherapy: Strong Emotions Decide But Rational Studies Are Needed
2008
Intensity-modulated Radiotherapy in the Treatment of Lung Cancer
2012
IDH1andIDH2Mutations in Gliomas
2009 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
2010
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Advances in Radiation Therapy for Brain Tumors
2007
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
2015
Guidelines on the radical management of patients with lung cancer
2010
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer
2004
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
2010
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy
2006
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline
2012
Relationship Between Neurocognitive Function and Quality of Life After Whole-Brain Radiotherapy in Patients With Brain Metastasis
2008
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Brain metastases: current management and new developments
2008
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Treatment of Stage IV Non-small Cell Lung Cancer
2013
Primary brain tumours in adults
2012 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Defining target volumes for non-small cell lung carcinoma
2004
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
ATP citrate lyase inhibition can suppress tumor cell growth
2005
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
2003
A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
2008
Local treatments for metastases of renal cell carcinoma: a systematic review
2014
Small Cell Lung Cancer
2008
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
2004
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Mitochondria and cell death: outer membrane permeabilization and beyond
2010 Standout
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation
2006
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
2004
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Small-cell lung cancer
2011
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases
2014
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
2007 Standout
Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel
2005
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Combination therapy in combating cancer
2017 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
2009
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
2004
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Brain Tumor Segmentation Using Convolutional Neural Networks in MRI Images
2016 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of David E. Morris being referenced
Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*
2003
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases
2005
Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
2008
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma
2005
Three-dimensional conformal radiation treatment planning and delivery for low- and intermediate-grade gliomas
2001
Current and evolving treatment options for limited stage small cell lung cancer
2006
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial
2002
Seeking a Home for a PET, Part 3
2004
CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience.
2004
O-310 Induction and concurrent chemotherapy with dose-escalated thoracic conformal radiation therapy (TCRT) in unresectable stage III A/B non-small cell lung cancer (NSCLC): A phase I trial
2003
Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial
2004
Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer
2004